BCM Researchers Discover New Method of Utilizing Banked T-Cells To Fight Viral Infections in Stem Cell Transplant Patients

Researchers from the Baylor College of Medicine have conducted a study which reveals the potential effectiveness of third party T-cells in combating viral infections in stem cell transplant patients.

http://bionews-tx.com/news/2013/05/16/bcm-researchers-discover-new-method-of-utilizing-banked-t-cells-to-fight-viral-infections-in-stem-cell-transplant-patients/

Sell Your Old AT&T Mobile Phone

Do you have an old AT&T mobile phone or smartphone? Sell it for fast cash at Phone Renew! Click here for a FREE quote!

http://www.phonerenew.com/provider_att/att-phones.html

Rice U. and Texas Children’s Hospital Researchers Determine That Heart Cells Change Stem Cell Behavior

Researchers at Houston’s Rice University and Texas Children’s Hospital have found that stem cells drawn from amniotic fluid show promise for tissue engineering, but it is important to determine what they can and cannot do. A new Rice/TCH study led by bioengineer Jeff Jacot has observed that amniotic stem cells can communicate with mature heart cells and form electrical couplings with each other similar to those found in heart tissue, but these electrical connections alone don’t result in the amniotic cells to become cardiac cells.

http://bionews-tx.com/news/2013/05/03/rice-u-and-texas-childrens-hospital-researchers-determine-that-heart-cells-change-stem-cell-behavior/

Opexa Therapeutics, Inc. CEO to Present at The Second International Vatican Adult Stem Cell Conference

Opexa Therapeutics, Inc., a biotechnology company based in The Woodlands, Texas, has announced that their President and Chief Executive Officer, Neil K. Warma, will be presenting at The Second International Vatican Adult Stem Cell Conference: Regenerative Medicine — A Fundamental Shift in Science & Culture, to be held at The Vatican this April 11-13, 2013. Opexa is known for its leading product, TcelnaTM, which individuals afflicted with multiple scelerosis can benefit largely from.

http://bionews-tx.com/news/2013/04/04/opexa-therapeutics-inc-ceo-to-present-at-the-second-international-vatican-adult-stem-cell-conference/

Newly-Formed Organization “The Health Cell” to Promote Biotech in San Antonio

A new nonprofit organization has officially formed in San Antonio that is designed to foster the collaboration and increase success of biotechnology in conjunction with academic, medical and military sectors. To achieve this goal, the just-announced organization, The Health Cell, has an executive committee and a board of directors made up of representatives from each of these sectors.

http://bionews-tx.com/news/2013/04/02/newly-formed-organization-the-health-cell-to-promote-biotech-in-san-antonio/

Bluebird Bio Collaborates With Celgene And Houston’s Center for Cell and Gene Therapy to Advance Gene Therapy in Oncology

Read about how Bluebird Bio Collaborates With Celgene And Houston’s Center for Cell and Gene Therapy to Advance Gene Therapy in Oncology

http://bionews-tx.com/news/2013/03/21/bluebird-bio-collaborates-with-celgene-and-houstons-center-for-cell-and-gene-therapy-to-advance-gene-therapy-in-oncology/

Cell Medica Appoints Former Texas Biotech Professional to Executive Staff, Establishes Houston Office

Read about how Cell Medica has Appointed Former Texas Biotech Professional to Executive Staff and has Established an office in Houston.

http://bionews-tx.com/news/cell-medica-appoints-former-texas-biotech-professional-to-executive-staff-establishes-houston-office/

Removing Key Genetic Roadblock Could Facilitate Conversion Of Adult Cells Into Stem Cells: Report

Read about how Removing a Key Genetic Roadblock Could Facilitate Conversion Of Adult Cells Into Stem Cells, according to a new Report.

http://bionews-tx.com/news/reprogramming-adult-cells-to-stem-cells-works-better-with-one-gene-turned-off-2/

Celltex Therapeutics Begins Cooperation With FDA to Resume Stem Cell Treatments

Texas-based adult stem cell treatment provider Celltex is apparently making strides in winning approval from the FDA, according to a recent wide-ranging article from Nature.com that outlines the controversial past and present of adult stem cell research and treatment. As a result of close scrutiny from the FDA in 2012 over what the organization deemed to be unproven treatment methods using adult stem cells, Celltex was forced to capitulate. After failing to argue effectively that stem cell treatments are in essence “tissue transplants” and not traditional drug treatments, thus not requiring the same rigorous clinical trials, the company was forced to move its treatment facilities to Mexico in order to continue to offer its patients ongoing stem cell treatment.

http://www.swbiosearch.com/2013/02/18/celltex-therapeutics-begins-cooperation-with-fda-toresume-stem-cell-treatments/

Gov. Rick Perry Urging Biotech Researchers to Commit to More Stem Cell Research

The Texas Governor is encouraging more growth in the Texas biotech and life sciences sectors by championing an increase in the often controversial stem cell research branch.

http://www.swbiosearch.com/gov-rick-perry-urging-biotech-researchers-to-commit-to-more-stem-cell-research/